Amanote Research

Amanote Research

    RegisterSign In

Application of Dynamic Modeling for Survival Estimation in Advanced Renal Cell Carcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0203406
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

August 30, 2018

Authors
Baris DenizArman AltincatalApoorva AmbavaneSumati RaoJustin DoanBill MalcolmM. Dror MichaelsonShuo Yang
Publisher

Public Library of Science (PLoS)


Related search

Management of Locally Advanced Renal Cell Carcinoma

Cancer Control
MedicineOncologyHematology
2006English

The Bevacizumab Experience in Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Clinical Medicine Insights: Oncology
Oncology
2011English

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2015English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy